Cross Linked Sub Skin Hyaluronic Acid

Product Introduction：

By harnessing exclusive patented purification technology and cutting-edge equipment, we achieve unparalleled product quality while significantly reducing production costs, maintaining a high safety profile that surpasses industry benchmarks for BDDE, endotoxin, and protein residue levels, utilizing a BDDE cross-linking agent residue-free process to maximize product safety and longevity, featuring high elastic and viscous modulus for superior shaping results, low extrusion force for easier injection, and anesthetic ingredients to drastically reduce pain, categorizing the gel into single and double types based on process variation and further dividing it into five injection levels—sub-skin, deep, derm, fine, and micro cross-link—while offering flexible ODM and OEM customization to meet specific customer requirements.

Product Display：

Product Details:

Product Package:

Customer Feedback:

Raw Material Advantages：

1. The tunable degradation profile enables predictable absorption timelines that align with tissue regeneration processes.

2. CLHA hydrogels demonstrate exceptional shear-thinning behavior, allowing smooth injection through narrow-gauge needles while maintaining shape post-placement.

Development Process:

Company Introduction:

Jinan Grandwill Medical Technology Co., Ltd. - A 2014-established innovator combining medical device engineering with biomaterial science. Our 6 specialized production lines (including pre-filled syringes and automated applicators) operate within ISO 9001-certified cleanrooms, supported by 7 invention patents and 4 utility patents. The microbial testing laboratory ensures final products meet stringent EU MDR requirements, eliminating heavy metal traces through multi-stage filtration systems.The core team has been collaborating in the medical device field for over 15 years, with a well-balanced professional configuration, successfully developing, registering, and commercializing multiple Class III medical devices.